Hospital
Trinity Hospitals
Trinity Hospitals was paid $7.37M by Medicaid between Jan 2018 and Dec 2024, across 159 billing codes. Its largest line is 99284, emergency room visit (serious) — 40% of everything it billed.
33Billing provider infoTRINITY HOSPITALS
MINOT, ND 58701
MINOT, ND 58701
33aNPI1427103910assigned 01/24/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$7.37M
24GClaims166,361
24DCodes billed159
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in North Dakota
Rank by total paid#4 of 8
Median peer was paid$750K
This provider vs. median9.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official KUTCH, JOHN controls 12+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 50,139 | $1.48M | |
| 2019 | 18,835 | $914K | |
| 2020 | 17,442 | $853K | |
| 2021 | 25,523 | $1.59M | |
| 2022 | 22,244 | $1.04M | |
| 2023 | 20,083 | $938K | |
| 2024incomplete | 12,095 | $560K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 40% | 9,460 | 8,808 | $2.93M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 26% | 8,978 | 8,434 | $1.91M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.3% | 1,622 | 1,491 | $614K |
| G0378 | Hospital observation service, per hour | 3.6% | 266 | 223 | $263K |
| S0201 | Partial hospitalization services, less than 24 hours, per diem | 3.1% | 507 | 51 | $229K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.3% | 1,473 | 1,384 | $170K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.1% | 256 | 239 | $158K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.5% | 4,439 | 4,089 | $107K |
| 80053 | Comprehensive metabolic panel | 1.3% | 18,144 | 16,007 | $97K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.0% | 695 | 424 | $74K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 1,252 | 282 | $68K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 8,167 | 6,867 | $49K |
147 more codes
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 779 | $46K |
| 36415 | Collection of venous blood by venipuncture | <1% | 26,007 | $45K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,325 | $43K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 134 | $39K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 622 | $35K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,829 | $33K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 18,968 | $30K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,987 | $29K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,200 | $26K |
| 85027 | <1% | 3,410 | $23K | |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 321 | $23K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 150 | $23K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 606 | $19K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,161 | $15K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 327 | $15K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 204 | $14K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 909 | $14K |
| 81001 | <1% | 6,139 | $11K | |
| 73630 | <1% | 305 | $10K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 127 | $10K |
| 71045 | Radiologic examination, chest; single view | <1% | 863 | $10K |
| G0330 | Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room | <1% | 12 | $9K |
| 80061 | Lipid panel | <1% | 679 | $9K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 14 | $7K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 174 | $7K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 12 | $7K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 890 | $6K |
| 97161 | <1% | 91 | $6K | |
| 87480 | <1% | 274 | $6K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 16 | $6K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 773 | $6K |
| 87510 | <1% | 274 | $5K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 142 | $5K |
| 87660 | <1% | 274 | $5K | |
| 86850 | <1% | 388 | $5K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 55 | $5K |
| 87150 | <1% | 112 | $4K | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | <1% | 210 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,095 | $4K |
| 86900 | <1% | 304 | $4K | |
| 86780 | <1% | 321 | $4K | |
| 0240U | <1% | 49 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 501 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 192 | $4K |
| 86140 | <1% | 417 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 545 | $3K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 37 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 246 | $3K |
| 87070 | <1% | 432 | $3K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 48 | $3K |
| 82728 | <1% | 234 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 113 | $3K |
| 77334 | <1% | 27 | $3K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 13 | $2K |
| 80050 | General health panel | <1% | 58 | $2K |
| 81003 | <1% | 782 | $2K | |
| 87522 | Neg quan hep c or qual rna | <1% | 55 | $2K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,978 | $2K |
| 84481 | <1% | 139 | $2K | |
| 87186 | <1% | 220 | $1K | |
| 93017 | <1% | 13 | $1K | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,680 | $1K |
| 87077 | <1% | 216 | $1K | |
| 87081 | <1% | 137 | $1K | |
| 85652 | <1% | 411 | $1K | |
| 82607 | <1% | 141 | $1K | |
| 87340 | <1% | 113 | $1K | |
| 83516 | <1% | 14 | $969.68 | |
| 84439 | <1% | 168 | $922.42 | |
| A9270 | Non-covered item or service | <1% | 5,629 | $917.56 |
| 80306 | <1% | 211 | $915.97 | |
| 20610 | <1% | 35 | $863.99 | |
| 85610 | <1% | 535 | $854.48 | |
| 74018 | <1% | 85 | $853.40 | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 17 | $751.38 |
| 86762 | <1% | 45 | $697.68 | |
| 87807 | <1% | 76 | $683.14 | |
| J3490 | Unclassified drugs | <1% | 1,193 | $660.06 |
| 86901 | <1% | 304 | $627.58 | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 351 | $625.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 42 | $598.50 |
| 86803 | <1% | 45 | $592.61 | |
| 86592 | <1% | 137 | $566.80 | |
| 82950 | <1% | 93 | $509.04 | |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 253 | $464.25 |
| 83735 | <1% | 474 | $461.09 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,002 | $396.16 |
| 87147 | <1% | 92 | $356.43 | |
| 83690 | <1% | 546 | $333.92 | |
| 84146 | <1% | 19 | $321.36 | |
| 92134 | <1% | 514 | $311.77 | |
| 73501 | <1% | 12 | $292.46 | |
| 84484 | <1% | 532 | $274.26 | |
| 82570 | <1% | 57 | $224.18 | |
| 83540 | <1% | 95 | $221.45 | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 128 | $198.37 |
| 83550 | <1% | 68 | $187.43 | |
| 97162 | <1% | 15 | $184.37 | |
| 87040 | <1% | 40 | $164.91 | |
| 85007 | <1% | 111 | $142.56 | |
| 80076 | <1% | 13 | $134.85 | |
| 82784 | <1% | 17 | $130.48 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 398 | $124.00 |
| 81025 | <1% | 162 | $119.58 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 82 | $118.81 |
| 85730 | <1% | 103 | $107.38 | |
| 84703 | <1% | 733 | $97.30 | |
| 87205 | <1% | 34 | $87.20 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,457 | $85.57 |
| 84156 | <1% | 27 | $79.40 | |
| 11721 | <1% | 531 | $59.93 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 1,078 | $56.87 |
| 82746 | <1% | 13 | $56.25 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 231 | $48.81 |
| 82550 | <1% | 450 | $41.55 | |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | <1% | 32 | $35.04 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 519 | $16.23 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,117 | $13.22 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,361 | $6.52 |
| 82962 | <1% | 310 | $5.88 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 12 | $4.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 503 | $1.70 |
| 96376 | 0% | 137 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 403 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 98 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 95 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 168 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 53 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 39 | $0.00 |
| C1769 | Guide wire | 0% | 17 | $0.00 |
| 83605 | 0% | 18 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 29 | $0.00 |
| Q3014 | Telehealth originating site facility fee | 0% | 12 | $0.00 |
| 87500 | 0% | 14 | $0.00 | |
| 88304 | 0% | 12 | $0.00 | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 0% | 174 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 51 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 15 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 155 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 18 | $0.00 |
| 93296 | 0% | 27 | $0.00 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 47 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 13 | $0.00 |
| J0897 | Injection, denosumab, 1 mg | 0% | 13 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 63 | $0.00 |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 0% | 17 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKUTCH, JOHN (PRESIDENT & CEO)
Parent organizationTRINITY HEALTH
| Provider | Location | Paid |
|---|---|---|
| Trinity Health | Minot, ND | $18.68M |
| Trinity Hospitals | Minot, ND | $3.47M |
| Trinity Health | Minot, ND | $872K |
| Trinity Hospitals | Belcourt, ND | $750K |
| Trinity Hospitals | Minot, ND | $356K |
| Medical Arts Outpatient Services, INC. | Minot, ND | $210K |
| Trinity Health | Minot, ND | $97K |
| Trinity Health | Williston, ND | $69K |
| Trinity Hospitals | Minot, ND | $42K |
| Medical Arts Outpatient Services, INC. | Minot, ND | $26K |
| Trinity Kenmare Hospital | Kenmare, ND | $11K |
| Trinity Health | Williston, ND | $7K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.